Search

Search Constraints

You searched for: Author/Creator Zolk, Oliver

Search Results

1. A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3. Issue 1 (24th June 2021)

2. Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross-sectional AMSP study. (28th May 2022)

3. CTNI-04. RECURRENT GLIOBLASTOMA LONG-TERM SURVIVORS TREATED WITH CUSP9v3. (12th November 2021)

4. Focused screening of a panel of cancer‐related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemia. Issue 8 (6th March 2014)

5. Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis. (May 2021)

6. PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents. (November 2018)

7. Pediatric Colorectal Carcinoma is Associated With Excellent Outcome in the Context of Cancer Predisposition Syndromes. Issue 4 (17th November 2015)

8. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function. Issue 4 (14th February 2021)

9. The role of genetic polymorphisms in the thymidylate synthase (TYMS) gene in methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia. Issue 10 (October 2018)

10. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. (October 2020)